newsfilter
← Latest News
ACCESS Newswire·

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in March 2026

  • Protagonist Therapeutics announced that CEO Dinesh Patel will participate in multiple investment bank conferences in March 2026.
  • The company will present at the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026.
  • Participation is scheduled for the Leerink Global Healthcare Conference in Miami on March 9, 2026.
  • One-on-one meetings are available at the Jefferies Biotech on the Beach Summit in Miami on March 10, 2026.
  • A fireside chat is set for the Citizens Life Sciences Conference in Miami on March 11, 2026.
  • The Barclays 28th Annual Global Healthcare Conference in Miami will feature a fireside chat on March 12, 2026.
  • Webcasts for the TD Cowen, Leerink, Citizens, Barclays events are available via provided links.
  • Replays of presentations will be accessible on the company's Investor Relations webpage for one year.
  • Icotrokinra, an IL-23R antagonist licensed to Janssen, has an NDA submitted to the FDA in July.
  • Rusfertide, a hepcidin mimetic for polycythemia vera co-developed with Takeda, had an NDA submitted in December 2025.
  • The company maintains preclinical programs including PN-881, PN-477, an oral hepcidin program.